Cargando…
Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation
The bacterial pathogens of the genus Yersinia, the causative agents of plague, septicemia, and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212976/ https://www.ncbi.nlm.nih.gov/pubmed/16301742 http://dx.doi.org/10.1084/jem.20051194 |
_version_ | 1782148799339167744 |
---|---|
author | Zhou, Honglin Monack, Denise M. Kayagaki, Nobuhiko Wertz, Ingrid Yin, Jianpin Wolf, Beni Dixit, Vishva M. |
author_facet | Zhou, Honglin Monack, Denise M. Kayagaki, Nobuhiko Wertz, Ingrid Yin, Jianpin Wolf, Beni Dixit, Vishva M. |
author_sort | Zhou, Honglin |
collection | PubMed |
description | The bacterial pathogens of the genus Yersinia, the causative agents of plague, septicemia, and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block host proinflammatory responses by inhibiting both the nuclear factor κB (NF-κB) and mitogen-activated protein kinase pathways, which might be important for evasion of the host immune response and aid in establishing a systemic infection. Here, we show that YopJ is a promiscuous deubiquitinating enzyme that negatively regulates signaling by removing ubiquitin moieties from critical proteins, such as TRAF2, TRAF6, and IκBα. In contrast to the cylindromatosis tumor suppressor CYLD, which attenuates NF-κB signaling by selectively removing K63-linked polyubiquitin chains that activate IκB kinase, YopJ also cleaves K48-linked chains and thereby inhibits proteasomal degradation of IκBα. YopJ, but not a catalytically inactive YopJ mutant, promoted deubiquitination of cellular proteins and cleaved both K48- and K63-linked polyubiquitin. Moreover, an in vitro assay was established to demonstrate directly the deubiquitinating activity of purified YopJ. |
format | Text |
id | pubmed-2212976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22129762008-03-11 Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation Zhou, Honglin Monack, Denise M. Kayagaki, Nobuhiko Wertz, Ingrid Yin, Jianpin Wolf, Beni Dixit, Vishva M. J Exp Med Brief Definitive Report The bacterial pathogens of the genus Yersinia, the causative agents of plague, septicemia, and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block host proinflammatory responses by inhibiting both the nuclear factor κB (NF-κB) and mitogen-activated protein kinase pathways, which might be important for evasion of the host immune response and aid in establishing a systemic infection. Here, we show that YopJ is a promiscuous deubiquitinating enzyme that negatively regulates signaling by removing ubiquitin moieties from critical proteins, such as TRAF2, TRAF6, and IκBα. In contrast to the cylindromatosis tumor suppressor CYLD, which attenuates NF-κB signaling by selectively removing K63-linked polyubiquitin chains that activate IκB kinase, YopJ also cleaves K48-linked chains and thereby inhibits proteasomal degradation of IκBα. YopJ, but not a catalytically inactive YopJ mutant, promoted deubiquitination of cellular proteins and cleaved both K48- and K63-linked polyubiquitin. Moreover, an in vitro assay was established to demonstrate directly the deubiquitinating activity of purified YopJ. The Rockefeller University Press 2005-11-21 /pmc/articles/PMC2212976/ /pubmed/16301742 http://dx.doi.org/10.1084/jem.20051194 Text en Copyright © 2005, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Brief Definitive Report Zhou, Honglin Monack, Denise M. Kayagaki, Nobuhiko Wertz, Ingrid Yin, Jianpin Wolf, Beni Dixit, Vishva M. Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation |
title |
Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation |
title_full |
Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation |
title_fullStr |
Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation |
title_full_unstemmed |
Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation |
title_short |
Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation |
title_sort | yersinia virulence factor yopj acts as a deubiquitinase to inhibit nf-κb activation |
topic | Brief Definitive Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212976/ https://www.ncbi.nlm.nih.gov/pubmed/16301742 http://dx.doi.org/10.1084/jem.20051194 |
work_keys_str_mv | AT zhouhonglin yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation AT monackdenisem yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation AT kayagakinobuhiko yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation AT wertzingrid yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation AT yinjianpin yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation AT wolfbeni yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation AT dixitvishvam yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation |